Triggering apoptosis in hematopoietic cells with cytotoxic drugs

19Citations
Citations of this article
18Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Cytotoxic agents are commonly added to cultured cells in the laboratory to investigate their efficacy, mechanism of action, and therapeutic potential. Most of these agents trigger cell death by apoptosis, which is also the most common form of cell death during development, aging, homeostasis, and eradication of disease. Treatment of cells with cytotoxic agents is therefore useful for investigating basic mechanisms of cell death in the human body. Actinomycin D, a cytotoxic agent isolated from Streptomyces, induces apoptosis in a variety of cell lines including the histiocytic lymphoma cell line U937. Treatment of U937 cells with actinomycin D provides an ideal model of drug-induced apoptosis that can also be used as a positive control for comparison with other treatments.

Cite

CITATION STYLE

APA

Crowley, L. C., Marfell, B. J., Scott, A. P., & Waterhouse, N. J. (2016). Triggering apoptosis in hematopoietic cells with cytotoxic drugs. Cold Spring Harbor Protocols, 2016(7), 635–638. https://doi.org/10.1101/pdb.prot087130

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free